Fallopian Tube Neoplasms clinical trials

Explore recruiting fallopian tube neoplasms clinical trials.

Recruiting fallopian tube neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fallopian Tube Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

J5E-MC-JZXB - FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Netherlands, Hungary, France, Austria, Poland, Italy +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fallopian Tube Neoplasms trials by city

Fallopian Tube Neoplasms clinical trials

Recruiting fallopian tube neoplasms studies right now

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Study of AVZO-021 in Patients With Advanced Solid Tumors

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Using Aspirin to Improve Immunological Features of Ovarian Tumors

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Also recruiting in Europe

Fallopian Tube Neoplasms trials by city

Other conditions